{"schema_version":"secwatch.filing_event.v1","accession":"0001664710-24-000047","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2024-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.491870+00:00","generated_at":"2026-06-01T06:50:33.622397+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Keros Therapeutics CEO to present at Goldman Sachs Healthcare Conference June 10","bullets":["CEO Jasbir S. Seehra, Ph.D., to participate in fireside chat at Goldman Sachs 45th Annual Healthcare Conference.","Presentation scheduled for June 10, 2024 at 2:40 p.m. Eastern time.","Live webcast available; archived replay accessible for 90 days on Keros website."],"urls":{"canonical":"https://secwatch.observer/filing/0001664710-24-000047","json":"https://secwatch.observer/filing/0001664710-24-000047.json","markdown":"https://secwatch.observer/filing/0001664710-24-000047.md","text":"https://secwatch.observer/filing/0001664710-24-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000166471024000047/0001664710-24-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000166471024000047/kros-20240603.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:50:33.622397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}